NCT04063267View on ClinicalTrials.gov

Electronic Cigarettes as a Harm Reduction Strategy in Individuals With Substance Use Disorder

PHASE2CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

October 27, 2020

Primary Completion Date

June 1, 2024

Study Completion Date

June 30, 2024

Conditions
Cigarette SmokingAddictionE Cig Use
Interventions
OTHER

E cigarettes

Participants will be encouraged to substitute e-cigarettes for combustible cigarettes in order to reduce nicotine withdrawal symptoms

OTHER

Nicotine Replacement Therapy

Nicotine patches and gum to last them the first week based on their baseline recorded smoking. Participants will be advised to use both a 21 mg nicotine patch and 4 mg nicotine for cravings.

Trial Locations (1)

10016

NYU Langone Health, New York

All Listed Sponsors
lead

NYU Langone Health

OTHER

NCT04063267 - Electronic Cigarettes as a Harm Reduction Strategy in Individuals With Substance Use Disorder | Biotech Hunter | Biotech Hunter